Danielle joined KCL in 2022 to work on RECOLLECT, a five-year research program funded by the NIHR, which explores the effectiveness and cost-effectiveness of Recovery Colleges across England. Prior to this Danielle worked at the Mental Health Research Delivery Dept, a part of Oxford Health Foundation Trust, and the University of Oxford, Psychiatry Department. During this time, Danielle would lead on various research projects, included but not limited to interventional and non-interventional clinical trials, observational and case-control studies. Danielle has worked in mental health services for 5 years gaining experience in diverse roles supporting those with complex mental health difficulties.
Danielle completed her BSc Psychology at University of Chichester during 2013-2016 and MSc Neuroscience at IOPPN 2018-2019 where she completed a specialized module in Psychiatric Genetics.
Danielle has interests in 1) Psychopharmacology in Schizophrenia 2) Mental Health Services/Care, and 3) Recovery in Mental Health.
Psychopharmacology in Schizophrenia
- New treatments – Long-acting Oral Antipsychotic Medications.
- Antipsychotic Discontinuation or Reduction.
Mental Health Services
- Recovery Colleges.
- Inpatients Units – Psychiatric Intensive Care Units.
Recovery in Mental Health
- Self-management and Decision Making.
- Self-Care Techniques and Treatments.
Expertise and Public Engagement
Service Quality Audit for IAPT services across Oxfordshire and Buckinghamshire on ‘Views of Remote Talking Therapy during COVID-19’ a qualitative report. CBT Today.
Dunnett D, Oloyede E, Oduniyi O, Arroyo B, Dzahini O, Taylor D, Shergill SS, Whiskey E. Evaluation of the effectiveness and acceptability of the long-acting oral antipsychotic penfluridol: Illustrative case series. J Psychopharmacol. 2021 Oct 27:2698811211050561. doi: 10.1177/02698811211050561. Epub ahead of print. PMID: 34702106.